Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 1 of 1
Full-Text Articles in Molecular Biology
Changes In Alternative Splicing As Pharmacodynamic Markers For Sudemycin D6, Morgan Thurman, Jacob Van Doorn, Barbara Danzer, Thomas R. Webb, Stefan Stamm
Changes In Alternative Splicing As Pharmacodynamic Markers For Sudemycin D6, Morgan Thurman, Jacob Van Doorn, Barbara Danzer, Thomas R. Webb, Stefan Stamm
Molecular and Cellular Biochemistry Faculty Publications
Objective:
The aim of the study was to define pharmacodynamic markers for sudemycin D6, an experimental cancer drug that changes alternative splicing in human blood.
Methods:
Blood samples from 12 donors were incubated with sudemycin D6 for up to 24 hours, and at several time points total RNA from lymphocytes was prepared and the pre-messenger RNA (mRNA) splicing patterns were analyzed with reverse transcription-polymerase chain reaction.
Results:
Similar to immortalized cells, blood lymphocytes change alternative splicing due to sudemycin D6 treatment. However, lymphocytes in blood respond slower than immortalized cultured cells.
Conclusions:
Exon skipping in the DUSP11 and SRRM1 pre-mRNAs …